MR. GANG GARY TIAN M.D NPI 1528066495

NPI Information

  • NPI: 1528066495
  • Provider Name: MR. GANG GARY TIAN, M.D
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7945 WOLF RIVER BOULEVARD
    GERMANTOWN, TN
    ZIP 38138
  • Phone: (901) 683-0055

Map and Directions

Get Directions

NPI Details

MR. Gang Gary Tian, M.D is a hematology and oncology internal medicine in Germantown, TN with 30 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. MR. Gang Gary Tian, M.D NPI is 1528066495. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7945 WOLF RIVER BOULEVARD
GERMANTOWN, TN
ZIP 38138
Phone: (901) 683-0055
Fax: (901) 922-6701

The NPI 1528066495 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
  • Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
  • Injection, lanreotide, 1 mg (HCPCS:J1930)
  • Injection, carfilzomib, 1 mg (HCPCS:J9047)
  • Injection, docetaxel, 1 mg (HCPCS:J9171)
  • Injection, durvalumab, 10 mg (HCPCS:J9173)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Liver function blood test panel (HCPCS:80076)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, etoposide, 10 mg (HCPCS:J9181)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, irinotecan, 20 mg (HCPCS:J9206)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
  • Magnesium level (HCPCS:83735)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Unclassified drugs (HCPCS:J3490)
  • Nephelometry, test method using light (HCPCS:83883)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Blood creatinine level (HCPCS:82565)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes (HCPCS:97110)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Blood test, clotting time (HCPCS:85610)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Therapy procedure using functional activities (HCPCS:97530)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Training for self-care or home management, each 15 minutes (HCPCS:97535)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Injection, mannitol, 25% in 50 ml (HCPCS:J2150)
  • Folic acid level, serum (HCPCS:82746)
  • Red blood count, automated test (HCPCS:85045)
  • Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Automated urinalysis test (HCPCS:81003)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Blood glucose (sugar) level (HCPCS:82947)
  • Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Declotting of central venous tube (HCPCS:36593)
  • Injection of drug or substance into vein (HCPCS:96374)

The enumeration date for this NPI number is 7/13/2005 and was last updated on 7/10/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology18163MISSISSIPPINo
2207RH0003XInternal MedicineHematology & OncologyE3740ARKANSASNo
3207RH0003XInternal MedicineHematology & Oncology37455TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
14156741OTHERTENNESSEETN BCBS
241026OTHERTENNESSEETLC
33000362MEDICAIDTENNESSEE
45M939OTHERARKANSASAR BCBS
59265094OTHERTENNESSEECIGNA
600407367MEDICAIDMISSISSIPPI
7159905001MEDICAIDARKANSAS
87176524OTHERTENNESSEEAETNA
9208389015MEDICAIDMISSOURI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.